(Q29616465)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7664346

30 April 2017

Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control (English)

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

30 July 2024

author name string

C. Deng

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7664346

30 July 2024

P. Zhang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7664346

30 July 2024

J. W. Harper

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7664346

30 July 2024

S. J. Elledge

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7664346

30 July 2024

P. Leder

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7664346

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7664346

30 July 2024

language of work or name

1 reference

30 April 2017

publication date

25 August 1995

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7664346

full work available at URL

30 April 2017

https://doi.org/10.1016/0092-8674(95)90039-x

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7664346

https://api.elsevier.com/content/article/PII:009286749590039X?httpAccept=text/xml

30 July 2024

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

https://api.elsevier.com/content/article/PII:009286749590039X?httpAccept=text/plain

30 July 2024

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

30 July 2024

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7664346

30 April 2017

volume

82

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7664346

30 April 2017

issue

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7664346

30 April 2017

page(s)

675-84

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7664346

A single ataxia telangiectasia gene with a product similar to PI-3 kinase

30 April 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.7792600

Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.7973727

Accumulation of wild-type p53 protein upon gamma-irradiation induces a G2 arrest-dependent immunoglobulin kappa light chain gene expression.

1

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

mdm2 expression is induced by wild type p53 activity

30 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Growth factor modulation of p53-mediated growth arrest versus apoptosis

30 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Thymocyte apoptosis induced by p53-dependent and independent pathways.

30 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage.

30 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

A p53-dependent mouse spindle checkpoint

30 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Murine FGFR-1 is required for early postimplantation growth and axial organization

30 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts

30 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

30 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

30 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

WAF1, a potential mediator of p53 tumor suppression

30 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis

30 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Cdk inhibitors: on the threshold of checkpoints and development

30 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15

30 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.

30 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.

30 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells

30 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Cell cycle control and cancer

30 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

30 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Inhibition of cyclin-dependent kinases by p21

30 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.

30 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

30 July 2024

Tumor suppressor genes

24

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

p53 mutations in human cancers

30 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Tumor spectrum analysis in p53-mutant mice

30 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Expression of wild-type p53 is not compatible with continued growth of p53-negative tumor cells

30 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Participation of p53 protein in the cellular response to DNA damage

30 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

30 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Wild-type p53 is a cell cycle checkpoint determinant following irradiation

30 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution

30 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53

30 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

p53 is required for radiation-induced apoptosis in mouse thymocytes

30 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage

30 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

UV Irradiation Stimulates Levels of p53 Cellular Tumor Antigen in Nontransformed Mouse Cells

30 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene

30 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

30 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen

30 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Molecular cloning and identification of two types of hamster cyclin-dependent kinases: cdk2 and cdk2L.

30 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Human cyclin E, a nuclear protein essential for the G1-to-S phase transition

30 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells

30 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

30 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Inhibitors of mammalian G1 cyclin-dependent kinases

30 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry

30 July 2024

55

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

30 July 2024

56

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene

30 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA

30 July 2024

58

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Cooperative tumorigenic effects of germline mutations in Rb and p53

30 July 2024

60

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

The p53-mdm-2 autoregulatory feedback loop

30 July 2024

61

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

p21 is a universal inhibitor of cyclin kinases

30 July 2024

62

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Multiple members of the E2F transcription factor family are the products of oncogenes

30 July 2024

63

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X

Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

30 July 2024

64

1 reference

https://api.crossref.org/works/10.1016/0092-8674(95)90039-X